MacMillan TE, et al. Osmotic demyelination syndrome in patients hospitalized with hyponatremia. NEJM Evid 2023; 2:1–9. https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200215
Shah MK, et al. Osmotic demyelination unrelated to hyponatremia. Am J Kidney Dis 2018; 71:436–440. doi: 10.1053/j.ajkd.2017.10.010
Burns JD, et al. Central pontine myelinolysis in a patient with hyperosmolar hyperglycemia and consistently normal serum sodium. Neurocrit Care 2009; 11:251–254. doi: 10.1007/s12028-009-9241-9
Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342:1581–1589. doi: 10.1056/NEJM200005253422107
Geoghegan P, et al. Sodium correction practice and clinical outcomes in profound hyponatremia. Mayo Clin Proc 2015; 90:1348–1355. doi: 10.1016/j.mayocp.2015.07.014
Aegisdottir H, et al. Incidence of osmotic demyelination syndrome in Sweden: A nationwide study. Acta Neurol Scand 2019; 140:342–349. doi: 10.1111/ane.13150
Nzerue CM, et al. Predictors of outcome in hospitalized patients with severe hyponatremia. J Natl Med Assoc 2003; 95:335–343. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2594506/
Vu T, et al. Grossmann M. Patients presenting with severe hypotonic hyponatremia: Etiological factors, assessment, and outcomes. Hosp Pract (1995) 2009; 37:128–136. doi: 10.3810/hp.2009.12.266
Sterns RH. Severe symptomatic hyponatremia: Treatment and outcome. A study of 64 cases. Ann Intern Med 1987; 107:656–664. doi: 10.7326/0003-4819-107-5-656
Sterns RH, et al. Neurologic sequelae after treatment of severe hyponatremia: A multicenter perspective. J Am Soc Nephrol 1994; 4:1522–1530. doi: 10.1681/ASN.V48152